Download MendeleyRole of Arginine 214 in the Substrate Specificity of OXA-48.
Oueslati, S., Retailleau, P., Marchini, L., Berthault, C., Dortet, L., Bonnin, R.A., Iorga, B.I., Naas, T.(2020) Antimicrob Agents Chemother 64
- PubMed: 32071047
- DOI: https://doi.org/10.1128/AAC.02329-19
- Primary Citation of Related Structures:
5HFO - PubMed Abstract:
Increasing numbers of variants of the carbapenem-hydrolyzing class D β-lactamase OXA-48 are identified in Enterobacterales worldwide. Among them, OXA-181 and OXA-232 are of particular interest, as they differ from each other by a single amino acid substitution at position 214 (R in OXA-181 and S in OXA-232) that results in reduced carbapenem-hydrolyzing activity for OXA-232. To investigate the role of amino acid position 214 (AA214), the X-ray structure of OXA-232 was determined and AA214 of OXA-48 and of OXA-232 was replaced by G, L, D, E, S, R, and K using site-directed mutagenesis. These mutants were phenotypically characterized, and three mutants of OXA-232 were purified to study their steady-state kinetic properties. The X-ray structure of OXA-232 along with molecular modeling studies showed that the interaction via a salt bridge between R214 and D159 in OXA-48 is not possible with the G214 or S214 mutation. In contrast, with K214, which is also positively charged, the interaction with D159 is maintained. With the E214 mutant, an alternative binding conformation of imipenem that is not compatible with a nucleophilic attack by S70 was evidenced. Thus, imipenem has a very poor apparent affinity for the E214 mutant because of its nonproductive binding mode. Similarly, we could explain the lack of temocillin hydrolysis by the OXA-232-S214E mutant, which is due to the unfavorable interaction between the negatively charged R1 substituent of temocillin with the E214 residue. Overall, we demonstrate that AA214 in OXA-48-like β-lactamases is critical for the carbapenemase activity.
Organizational Affiliation:
EA7361 Structure, Dynamic, Function and Expression of Broad Spectrum β-Lactamases, UMR1184, Faculty of Medicine, LabEx LERMIT, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
